More Physical Activity, Less Sitting May Lower Risk for Stroke
Sedentary time, longer bouts in particular, may increase risk for stroke.
Thrombotic Disorders
Momelotinib Demonstrates Superiority Over Danazol in Thrombocytopenic Myelofibrosis
Researchers sought to compare the efficacy of momelotinib with danazol in patients with thrombocytopenic myelofibrosis who were symptomatic and anemic.
Antimicrobial Peptide LL‑37 Contributes to Thrombotic Complications in Patients With COVID‑19
Researchers sought to determine the role of LL-37 in patients with SARS-CoV-2 infection and whether it contributes to hypercoagulation.
Modified Cardiac Rehab May Cut Mortality Risk for Stroke Survivors
As part of stroke recovery program, modified cardiac rehab may lower all-cause one-year mortality, improve overall and cardiovascular function.
Catheter-Directed Thrombolysis Appears Safe and Effective for Postpartum Deep Venous Thrombosis
Researchers sought to determine whether catheter-directed thrombolysis would be effective in patients with postpartum iliofemoral deep venous thrombosis.
Addressing Psychological Distress After Venous Thromboembolism
Researchers are seeking to address the psychological impact of patients who have survived VTE.
Risk of Cardiotoxicity With Doxorubicin for DLBCL Does Not Include Ischemic Heart Disease, Stroke
A study compared patients with diffuse large B-cell lymphoma with a 1:10 cohort from the general population to determine the risk of cardiovascular events in patients receiving doxorubicin-containing regimens.
Rilzabrutinib Shows Promise in Immune Thrombocytopenia
Researchers sought to determine whether rilzabrutinib would be effective in treating immune thrombocytopenia.
Efgartigimod Looks Promising for Primary Immune Thrombocytopenia
The phase 3 ADVANCE trial evaluated the efficacy and safety of efgartigimod in 131 adults with primary ITP.
COVID-19 Linked to Increased Risk for DVT, PE, Bleeding
Rate ratios were highest for critical COVID-19, and during first versus second and third pandemic waves in Sweden.
- Loading...
Loading...
Next post in Thrombotic Disorders
Loading... 
Loading...